Sulfuric Acid

Sulfuric Acid

SCHEMBL4653389

O=S(=O)(O)O.O=S(=O)(O)O.OO.[NaH].[NaH]

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA5A P35218 2/20 0.75
CA5B Q9Y2D0 2/20 0.75
TSHR P16473 4/20 0.46
CA2 P00918 3/20 0.46
CA1 P00915 2/20 0.46
CA9 Q16790 2/20 0.46
NT5E P21589 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA7 P43166 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
BLM P54132 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL832784 1.00
Sulfuric Acid SCHEMBL420187 1.00 CA5A (0.75) CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL6879174 0.94 CA5A (0.67) CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL28907531 0.94
Sulfuric Acid SCHEMBL28823983 0.94
Sulfuric Acid SCHEMBL1749363 0.94 CA5A (0.67) CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL3145491 0.94 CA5A (0.67) CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL1921997 0.94 CA5A (0.86) CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL1014464 0.94 CA5A (0.86) CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL16013217 0.94 CA5A (0.86) CA5ACA5BTSHRCA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008100993-A1 DEODORANT COMPOSITIONS FOR BODY WASTE COLLECTORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-08-21 WO claimed
WO-2017094916-A1 GLYCEROL PRODUCTION PROMOTER DERIVED FROM Staphylococcus Epidermidis, ANTIMICROBIAL PEPTIDE PRODUCTION PROMOTER DERIVED FROM SKIN EPIDERMAL KERATINOCYTES, AND UTILIZATION THEREOF IN EXTERNAL PREPARATION FOR SKIN PROTECTION ICHIMARU PHARCOS CO., LTD. (JP) 2017-06-08 WO disclosed
CN-104828955-B Biological composite oxygen producer and preparation method thereof 山东宝来利来生物工程股份有限公司 2017-03-22 CN disclosed
CN-102924325-B Preparation method for staurosporine medical intermediate SHENZHEN SALUBRIS PHARM CO LTD 2013-08-28 CN disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
WO-2008100993-A1 DEODORANT COMPOSITIONS FOR BODY WASTE COLLECTORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-08-21 WO disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed
CN-1146653-C Method for producing crystalline alkali metal silicate granules and granular high density detergent ������������ʽ���� 2004-04-21 CN disclosed
EP-0882786-B1 HIGH-DENSITY POWDERED DETERGENT COMPOSITION KAO CORP (JP) 2003-07-23 EP disclosed
EP-0862611-A1 METHOD FOR PRODUCING CRYSTALLINE ALKALI METAL SILICATE GRANULES AND GRANULAR HIGH DENSITY DETERGENT Kao Corporation (JP) 1998-09-09 EP disclosed
US-5736501-A FREE-FLOWING; HIGH BULK DENSITY KAO CORPORATION (JP) 1998-04-07 US disclosed
WO-1997017422-A1 METHOD FOR PRODUCING CRYSTALLINE ALKALI METAL SILICATE GRANULES AND GRANULAR HIGH DENSITY DETERGENT KAO CORPORATION (JP) 1997-05-15 WO disclosed
CN-1123321-A Method for producing nonoionic detergent granules KAO CORP (JP) 1996-05-29 CN disclosed
US-5468516-A Agitation; coating with silicate or metal soap; powder fluidity, noncaking; bulk density KAO CORPORATION (JP) 1995-11-21 US disclosed
EP-0279016-B2 Powdered hair dye HOYU KK (JP) 1995-04-05 EP disclosed
EP-0513824-A2 Process for producing nonionic detergent granules KAO CORPORATION (JP) 1992-11-19 EP disclosed
US-4190551-A NONIONIC SURFACTANT AND WATER-INSOLUBLE, PHOSPHORUS-CONTAINING ALKALI METAL ALUMINOSILICATE KAO SOAP CO., LTD. (JP) 1980-02-26 US disclosed
US-4005182-A BLEACHES KAO SOAP CO., LTD. (JA) 1977-01-25 US disclosed
US-3979312-A SODIUM SULFATE-HYDROGEN PEROXIDE-SODIUM CHLORIDE KAO SOAP CO., LTD. (JA) 1976-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC CA5A 1988/4885CA5B 2235/4885TSHR 2220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.